Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Center, Open Label Study of Pharmacokinetics of Clinical Probes and Characteristics of Endogenous Biomarker for Drug-metabolizing Enzymes and Transporters in Chinese Older Adults

NCT05893849 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT05893849
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05893849 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Center, Open Label Study of Pharmacokinetics of Clinical Probes and Characteristics of Endogenous Biomarker for Drug-metabolizing Enzymes and Transporters in Chinese Older Adults
Lead sponsor
Peking University Third Hospital
Phase
Observational
Overall status
Unknown status
Start date
March 28, 2023
Completion date
April 30, 2024
Enrollment
624 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aging